Skip to content

Effect of celecoxib and ibuprofen versus placebo on pain after laparotomy in drug dependence

Effect of celecoxib and ibuprofen versus placebo on pain after laparotomy in drug dependence: a double-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201411269014N50
Enrollment
114
Registered
2014-12-02
Start date
2013-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Unspecified pain

Interventions

Intervention 1: 200 mg oral celecoxib single dose 1 hour before surgery. Intervention 2: 400 mg oral ibuprofen single dose 1 hour before surgery. Intervention 3: one tablet of vitamin B single dose 1
Treatment - Drugs
Placebo
200 mg oral celecoxib single dose 1 hour before surgery
400 mg oral ibuprofen single dose 1 hour before surgery
one tablet of vitamin B single dose 1 hour before surgery

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age of 18 to 60 years; (b) candidate for laparotomy; (c) drug dependence. Exclusion criteria: (a) using analgesic during 8 hours before surgery; (b) during pregnancy of breastfeeding; (c) sensitivity to celecoxib, ibuprofen, or vitamin B; (d) affected with cardiovascular diseases, renal diseases, liver diseases, and gastrointestinal diseases; (e) alcohol abuse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measuring the pain severity. Timepoint: 1 and 6 hours after surgery. Method of measurement: using VAS scale.

Secondary

MeasureTime frame
Number of narcotic or analgesic used. Timepoint: during the 6 hours after surgery. Method of measurement: by checking medical record.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Khorshidi

Elham Khorshidi

elhamkhorshidi1368@gmail.com+98 81 8264 0020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026